Inventor · disambiguated record
Chengcheng Zhang
Also filed as: ZHANG CHENGCHENG
18 granted patents·15 pending applications·85 citations·filing 2005–2025
92Inventor score
Files withUNIV TEXAS11PROVINCIAL HEALTH SERVICES AUTHORITY7WHITEHEAD BIOMEDICAL INST5UNIV BRITISH COLUMBIA3ZHANG CHENGCHENG3
Top patents by PatentIndex Score
33 records- 0195US7767453B2Cultured hematopoietic stem cells and method for expansion and analysis thereofWHITEHEAD BIOMEDICAL INST·Filed 2005·Granted Aug 3, 2010·38 cites·27 claims
- 0293US11395857B2Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Granted Jul 26, 2022·3 cites·33 claims
- 0393US7807464B2Methods for expansion and analysis of cultured hematopoietic stem cellsWHITEHEAD BIOMEDICAL INST·Filed 2006·Granted Oct 5, 2010·27 cites·39 claims
- 0488US11884714B2Cyclic peptide analogs of melanocortin and amanitin and methods of making suchUNIV BRITISH COLUMBIA·Filed 2022·Granted Jan 30, 2024·1 cites·1 claims
- 0588US10501538B2Anti-LILRB antibodies and their use in detecting and treating cancerUNIV TEXAS·Filed 2017·Granted Dec 10, 2019·5 cites·24 claims
- 0687US11396535B2Cyclic peptide analogs of melanocortin and amanitin and methods of making suchUNIV BRITISH COLUMBIA·Filed 2020·Granted Jul 26, 2022·2 cites·1 claims
- 0787US10370643B2LILRB2 and notch-mediated expansion of hematopoietic precursor cellsHUTCHINSON FRED CANCER RES·Filed 2015·Granted Aug 6, 2019·5 cites·19 claims
- 0885US12202895B2LILRB4 antibodies and uses thereofUNIV TEXAS·Filed 2019·Granted Jan 21, 2025·2 cites·42 claims
- 0978US2024350681A1Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 1076US12246076B2Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Granted Mar 11, 2025·0 cites·14 claims
- 1172US12427209B2Dual mode 18F-labelled theranostic compounds and uses thereofPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted Sep 30, 2025·1 cites·5 claims
- 1268US11992537B2Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted May 28, 2024·0 cites·20 claims
- 1368US11377491B2Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancerUNIV TEXAS·Filed 2018·Granted Jul 5, 2022·1 cites·10 claims
- 1467US2025250336A1Novel lilrb4 antibodies and uses thereofUNIV TEXAS·Filed 2025·Application pending·0 cites
- 1565US11498963B2Anti-LILRB antibodies and their use in detecting and treating cancerUNIV TEXAS·Filed 2019·Granted Nov 15, 2022·0 cites·15 claims
- 1661US2014234266A1Cultured Hematopoietic Stem Cells and Method for Expansion and Analysis ThereofWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 1759US2025172557A1Methods for identifying lilrb ligands and blocking antibodiesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 1859US2014017784A1Methods for Expansion and Analysis of Cultured Hematopoietic Stem CellsWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 1958US8617885B2Cultured hematopoietic stem cells and method for expansion and analysis thereofZHANG CHENGCHENG·Filed 2010·Granted Dec 31, 2013·0 cites·17 claims
- 2058US8609411B2Ex vivo expansion of human hematopoietic stem cellsZHANG CHENGCHENG·Filed 2008·Granted Dec 17, 2013·0 cites·20 claims
- 2157US2015174203A1Compositions And Methods For Modulating Pro-Inflammatory Immune ResponseICAHN SCHOOL MED MOUNT SINAI·Filed 2013·Application pending·0 cites
- 2257US2019330593A1Lilrb2 and notch-mediated expansion of hematopoietic precursor cellsHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
- 2357US2025195702A1Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2025·Application pending·0 cites
- 2455US2018177847A1Compositions and methods for modulating pro-inflammatory immune responseUNIV TEXAS·Filed 2017·Application pending·0 cites
- 2554US8506955B2Methods for expansion and analysis of cultured hematopoietic stem cellsZHANG CHENGCHENG·Filed 2010·Granted Aug 13, 2013·0 cites·19 claims
- 2652US11906519B2Methods for identifying LILRB-blocking antibodiesUNIV TEXAS·Filed 2017·Granted Feb 20, 2024·0 cites·26 claims
- 2752US2025186627A1Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 2852US2024101667A1Methods for identifying lilrb-blocking antibodiesUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2951US2014308747A1Ex Vivo Expansion of Human Hematopoietic Stem CellsWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 3051US2023235055A1Monoclonal antibodies against lilrb1 for diagnostic and therapeutic useUNIV TEXAS·Filed 2021·Application pending·0 cites
- 3146US2023270892A1Chelator compositions for radiometals and methods of using sameTRIUMF INC·Filed 2021·Application pending·0 cites
- 3245US2024018110A1Radiolabeled compounds targeting the prostate-specific membrane antigenUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 3341US11013704B2Compounds supports hematopoietic stem cells and red blood cellsUNIV TEXAS·Filed 2015·Granted May 25, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Chengcheng Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →